Kevin M. Bell

Bell, Kevin

Principal Washington, DC
202.517.6325
kmbell@pbnlaw.com

Expand all

Kevin Bell has a diverse practice representing national and multi-national corporations, startup companies, universities and organizations in complex intellectual property litigation and International Trade Commission (ITC) investigations involving patents, trademarks, trade secrets, trade dress and unfair competition. Mr. Bell has extensive experience in licensing intellectual property and regularly provides strategic counseling to entities regarding development and enforcement of intellectual property portfolios. He represents clients on matters before the Federal Trade Commission (FTC) and works closely with members of Porzio's regulatory and compliance practices on specific issues related to the Food and Drug Administration.

Mr. Bell is also actively involved with the firm's corporate practice, advising on intellectual property matters that arise in corporate mergers, acquisitions and other due diligence transactions. He is a firm leader, representing his peers as a member of Porzio's Management Committee. 

Mr. Bell's practice focuses primarily on litigating complex intellectual property disputes before federal district courts, the ITC, the Judicial Panel for Multidistrict Litigation, the U.S. Court of Appeals for the Federal Circuit and various alternative dispute resolution forums. Often, these disputes involve large patent portfolios and are litigated simultaneously in the U.S. and across multiple foreign jurisdictions. Mr. Bell represents companies in a broad range of technologies that include chemical, biotech, pharmaceutical, medical device, dietary supplement, software, semi-conductor and computer science related matters. Mr. Bell has developed a substantial practice representing U.S. and international companies and inventors in the life sciences industry, licensing and enforcing intellectual property rights in groundbreaking technologies and products. As part of his practice, Mr. Bell has successfully developed and implemented novel patent damages and economic theories to obtain substantial monetary damages awards on behalf of his clients.

Mr. Bell is frequently retained to counsel U.S. and international clients on managing and monetizing their intellectual property assets. He works with companies and universities to develop strategies that generate revenue from their intellectual property assets, while also advising on how to decrease costs in maintaining and exploiting existing portfolios. Mr. Bell has extensive experience in assisting clients in creatively and successfully licensing, selling and acquiring intellectual property in several industry sectors.

Mr. Bell also maintains a practice in the area of sports and entertainment law. He represents individual and corporate clients on a broad range of legal matters, including negotiating contracts, endorsements, advertising and merchandising agreements, media rights and protection of intellectual property relating to sports and celebrity clients.

Representative Matters/Clients
  • Becton Dickinson & Co. v. Tyco Healthcare LP – Represented Becton Dickinson in patent litigation regarding safety needles in the U.S. District Court for the District of Delaware.
  • MBO Laboratories, Inc., v. Becton Dickinson & Co. – Represented Becton Dickinson in patent litigation regarding safety needles in the U.S. District Court for the District of Massachusetts.
  • Pressure Products Medical Supplies, Inc. v. Greatbatch Medical, Inc. – Represented Greatbatch in patent litigation regarding valved, peelable/splittable introducers in the U.S. District Court for the Eastern District of Texas.
  • Biacore AB v. Thermo BioAnalysis, Inc. – Represented Biacore in patent litigation involving biosensors in the U.S. District Court for the District of Delaware.
  • Applera Corp. v. Bio-Rad Labs., MJ Research and Stratagene Corp. – Represented Stratagene in patent litigation involving Real Time qPCR machines in the U.S. District Court for the District of Connecticut.
  • Digene Corporation v. Ventana Medical System, Inc. and Beckman Coulter, Inc. – Represented Digene in patent litigation involving antibody detection kits and systems directed to human papillomavirus (HPV) in the U.S. District Court for the District of Delaware.
  • Enzo Biochem v. Digene Corporation – Represented Digene in patent litigation involving systems and methods for antibody detection of viruses in the U.S. District Court of Delaware.
  • Benitec Australia, Inc. v. Nucleonics Inc. - Represented Benitec in patent litigation involving RNAi technology in the U.S. District Court for the District of Delaware.
  • Stratagene Corp. v. Biometra GMBH and Biometra U.S., Inc. – Represented Stratagene in patent litigation involving T Gradient thermocyclers in the U.S. District Court for the Southern District of California.
  • Ajinomoto Co., Inc. v. Archer-Daniels Midland – Represented Ajinomoto in patent litigation involving methods using recombinant biotechnology to produce amino specific amino acids – threonine and lysine in the U.S. District Court for the District of Delaware.
  • Oxford Gene Technology, Ltd. v. Mergen Ltd., Clontech Laboratories, Inc. d/b/a BD Biosciences Clontech, PerkinElmer Life Sciences, Inc. – Represented Clontech in patent litigation involving nucleic acid array products in the U.S. District Court for the District of Delaware.
  • Clontech Laboratories, Inc. v. Life Technologies, Inc. (formerly Invitrogen Corp.) – Represented Clontech in a patent false marking case in the U.S. District Court for the District of Delaware.
  • Life Technologies, Inc. (formerly Invitrogen Corp.) v. Clontech Laboratories, Inc. – Represented Clontech in patent litigation involving RNase H- Reverse Transcriptase products in the U.S. District Court for the District of Maryland.
  • Life Technologies, Inc. (formerly Invitrogen Corp.) v. Stratagene Corp. – Represented Clontech in patent litigation involving RNase H- Reverse Transcriptase products in the U.S. District Court for the District of Maryland.
  • Flamel Technologies, S.A. v. Lupin Limited, et al. – Represented Flamel in ANDA patent litigation involving drug delivery systems in the U.S. District Court for the District of Maryland.
  • Flamel Technologies, S.A. v. Anchen Pharmaceuticals, Inc. - Represented Flamel in ANDA patent litigation involving drug delivery systems in the U.S. District Court for the District of Maryland.
  • OxyBand Technologies, Inc. v. Day & Zimmerman and O2S, LLC – Represented OxyBand in arbitration in Delaware involving oxygenated wound dressings before the American Arbitration Association.
Organizations/Memberships
  • International Trade Commission Trial Lawyers Association (ITCTLA)
  • Maryland Bar Association
  • International Society of Sports Nutrition
  • The Langley School, Board of Trustees
Publications
Speaking Engagements
  • "Revised New Dietary Ingredient Guidance," Natural Products Association webinar, August 17, 2016.
  • "What to Expect From FDA's Draft Guidance on NDIs," Natural Products Association webinar, January 20, 2016.
  • "Learn the Regulatory Playbook on Cosmetic Claims," Natural Products Association Expo East, Baltimore, MD, September 17, 2015.
  • "Patent Disputes 2012: Patent Reform and New Models for a New Market," West LegalEdcenter Patent Disputes Conference, Washington, DC, August 19, 2012.
  • "The Effect of U.S. Patent Reform on Patent Disputes," U.S. Patent Reform: Consequences for European Practitioners Seminar, Munich, Germany, April 3, 2012.
  • "U.S. Patent Reform: The New Standard," Webinar, October 3, 2011.

Practice

Industries

Related Media

Bar Admissions

Admitted to practice in Maryland
Practice Limited to Federal Courts and Agencies

  • United States Supreme Court
  • U.S. Court of Appeals, Federal Circuit
  • U.S. Court of Appeals, 4th Circuit
  • U.S. District Court, District of Maryland
  • U.S. District Court, Eastern District of Texas
  • U.S. District Court, District of Colorado
  • U.S. District Court, Eastern District of Wisconsin

Education

George Mason University School of Law, Arlington, VA, J.D., 1998

University of Miami, Miami, FL, B.A., 1990

Contact Address

1200 New Hampshire Avenue NW, Suite 710

Washington, DC 20036-6802

Phone: 202.517.1888

Fax: 202.517.6322